Projects per year
Personal profile
Research Strategic Pillar
The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Infectious/ Immunological Health
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
IND-enabling studies and a first in human trial of Zika virus in brain cancer
Xie, X. (PI)
Washington University in St. Louis ( Award # )
1/1/26 → 12/31/26
Project: Research project
-
Antibody Escaping Mechanism by Human Metapneumovirus
Xie, X. (PI)
10/6/25 → 10/5/26
Project: Research project
-
GUIDE: Generative Unconstrained Intelligent Drug Engineering
Xie, X. (PI)
Lawrence Livermore National Security , LLC ( Award #DEAC5207NA27344)
6/20/25 → 9/30/27
Project: Research project
-
SAVE Variant Pipeline-SARS-CoV-2 variants serum neutralization analysis
Xie, X. (PI)
American Type Culture Collection ( Award #AT002015)
9/26/23 → 9/25/28
Project: Research project
-
Involving the testing of compounds against SARS-CoV-2
Xie, X. (PI)
Atea Pharmaceuticsl, Inc ( Award # )
5/2/23 → 12/31/26
Project: Research project
-
1′- and 4′-Cyano Modified Adenosine Analogs Against Prototypic Flavivirus RNA-Dependent RNA Polymerases
Walker, S. M., Gordon, C. J., Tchesnokov, E. P., Sun, L., Zou, J., Xie, X., Riola, N. C., Cutillas, V., Du Pont, V., Zhao, X., Wang, T., Pitts, J., Siegel, D. S., Perry, J. K., Feng, J. Y., Bilello, J. P. & Götte, M., Feb 2026, In: Viruses. 18, 2, 257.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease Inhibitor
Papillon, J. P. N., Yuan, J., Hesse, M. J., Zhang, L., Robinson, R. I., Ware, N. F., Hornak, V., Karki, R. G., Kirrane, T., Garland, K., Joseph, S., Moquin, S. A., Lakshminarayana, S. B., Tandeske, L., Dovala, D., Knapp, M., Ornelas, E., Fuller, D., Ho, P. I. & Xie, X. & 15 others, , Feb 26 2026, In: Journal of medicinal chemistry. 69, 4, p. 3868-3886 19 p.Research output: Contribution to journal › Article › peer-review
Open Access -
From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrum
Khatua, K., Atla, S., Coleman, D., Blankenship, L. R., Alugubelli, Y. R., Vulupala, V., Guo, X. S., Xia, H., Kalveram, B. K., Walker, D. H., Hurst, B. L., Kumar, S., Cho, C. C. D., Sharma, S., Yang, K., Rabie, D., Nyalata, S., Neuman, B. W., Xie, X. & Xu, S. & 1 others, , Dec 2026, In: Nature communications. 17, 1, 2782.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Functional and structural basis of Omicron BA.3.2.1 spike
Wang, Y., Hu, Y., Chen, Z., Zou, J., Zhang, K., Ren, P., Shi, P.-Y., Liang, B. & Xie, X., Aug 25 2026, In: Cell Reports. 45, 8, 117812.Research output: Contribution to journal › Article › peer-review
Open Access -
HIF1A-dependent induction of alveolar miR-147b dampens SARS-CoV-2-associated ARDS via direct targeting of viral RNA
Yuan, X., Kim, J., Figarella, K., Wang, Y., Makarevich, O., Ruan, W., Hu, Y., Xie, X., Mills, T., Karmouty-Quintana, H., Chang, C. Y., Mangala, L. S., Rodriguez-Aguayo, C., Amero, P., Tran, T. T., Czopik, A. K., Huang, K., Wang, J., Polverino, F. & Lopez-Berestein, G. & 8 others, , 2026, (Accepted/In press) In: Anesthesiology.Research output: Contribution to journal › Article › peer-review